HEAD AND NECK (HNSCC)
Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug GI-108 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called GI-108 in people with advanced or metastatic solid tumors (cancers that have spread). The drug is designed to help the immune system fight cancer. The trial has two parts: first, finding a safe dose, and then seeing if it shrinks tumors. About 7…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New cancer pill shows promise in early trial
Disease control Recruiting nowThis study tests an experimental drug called CP-383 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if CP-383 can slow or stop cancer growth and to find the safest and most effective dose. About 150 participants will take th…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Simple blood test may predict head and neck cancer behavior
Knowledge-focused Recruiting nowThis observational study aims to see if a blood test can identify the same biological tumor types as tissue analysis in people with HPV-negative head and neck cancer. About 300 adults with locally advanced, curable cancer will give blood samples before and after treatment. Resear…
Matched conditions: HEAD AND NECK (HNSCC)
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 17, 2026 01:44 UTC